Literature DB >> 19726506

Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation.

Christiane Brohm1, Eike Steinmann, Martina Friesland, Ivo C Lorenz, Arvind Patel, Francois Penin, Ralf Bartenschlager, Thomas Pietschmann.   

Abstract

Hepatitis C virus (HCV) p7 is an integral membrane protein that forms ion channels in vitro and that is crucial for the efficient assembly and release of infectious virions. Due to these properties, p7 was included in the family of viroporins that comprises proteins like influenza A virus M2 and human immunodeficiency virus type 1 (HIV-1) vpu, which alter membrane permeability and facilitate the release of infectious viruses. p7 from different HCV isolates sustains virus production with variable efficiency. Moreover, p7 determinants modulate processing at the E2/p7 and the p7/NS2 signal peptidase cleavage sites, and E2/p7 cleavage is incomplete. Consequently, it was unclear if a differential ability to sustain virus production was due to variable ion channel activity or due to alternate processing at these sites. Therefore, we developed a trans-complementation assay permitting the analysis of p7 outside of the HCV polyprotein and thus independently of processing. The rescue of p7-defective HCV genomes was accomplished by providing E2, p7, and NS2, or, in some cases, by p7 alone both in a transient complementation assay as well as in stable cell lines. In contrast, neither influenza A virus M2 nor HIV-1 vpu compensated for defective p7 in HCV morphogenesis. Thus, p7 is absolutely essential for the production of infectious HCV particles. Moreover, our data indicate that p7 can operate independently of an upstream signal sequence, and that a tyrosine residue close to the conserved dibasic motif of p7 is important for optimal virus production in the context of genotype 2a viruses. The experimental system described here should be helpful to investigate further key determinants of p7 that are essential for its structure and function in the absence of secondary effects caused by altered polyprotein processing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726506      PMCID: PMC2772676          DOI: 10.1128/JVI.00691-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Electrotransfection with "intracellular" buffer.

Authors:  M J van den Hoff; V M Christoffels; W T Labruyère; A F Moorman; W H Lamers
Journal:  Methods Mol Biol       Date:  1995

2.  Two hepatitis C virus glycoprotein E2 products with different C termini.

Authors:  H Mizushima; M Hijikata; S Asabe; M Hirota; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

3.  Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.

Authors:  F Ciampor; P M Bayley; M V Nermut; E M Hirst; R J Sugrue; A J Hay
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

4.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

5.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

6.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.

Authors:  C Lin; B D Lindenbach; B M Prágai; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes.

Authors:  Hang M Pham; Enrique R Argañaraz; Bettina Groschel; Didier Trono; Juan Lama
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication.

Authors:  Peter Friebe; Julien Boudet; Jean-Pierre Simorre; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

10.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

View more
  43 in total

1.  Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers.

Authors:  Jun-Xia Lu; Simon Sharpe; Rodolfo Ghirlando; Wai-Ming Yau; Robert Tycko
Journal:  Protein Sci       Date:  2010-10       Impact factor: 6.725

2.  NMR structure and ion channel activity of the p7 protein from hepatitis C virus.

Authors:  Roland Montserret; Nathalie Saint; Christophe Vanbelle; Andrés Gerardo Salvay; Jean-Pierre Simorre; Christine Ebel; Nicolas Sapay; Jean-Guillaume Renisio; Anja Böckmann; Eike Steinmann; Thomas Pietschmann; Jean Dubuisson; Christophe Chipot; François Penin
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 3.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

4.  Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy.

Authors:  Joseph Shaw; Rajendra Gosain; Monoj Mon Kalita; Toshana L Foster; Jayakanth Kankanala; D Ram Mahato; Sonia Abas; Barnabas J King; Claire Scott; Emma Brown; Matthew J Bentham; Laura Wetherill; Abigail Bloy; Adel Samson; Mark Harris; Jamel Mankouri; David J Rowlands; Andrew Macdonald; Alexander W Tarr; Wolfgang B Fischer; Richard Foster; Stephen Griffin
Journal:  Elife       Date:  2020-11-10       Impact factor: 8.140

5.  Two methods of heterokaryon formation to discover HCV restriction factors.

Authors:  Anne Frentzen; Kathrin Hueging; Julia Bitzegeio; Thomas Pietschmann; Eike Steinmann
Journal:  J Vis Exp       Date:  2012-07-16       Impact factor: 1.355

6.  The intraviral protein interaction network of hepatitis C virus.

Authors:  Nicole Hagen; Karen Bayer; Kathrin Rösch; Michael Schindler
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

7.  A Coronavirus E Protein Is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway.

Authors:  Jason W Westerbeck; Carolyn E Machamer
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

Review 8.  Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

Authors:  Michael J Bouchard; Sonia Navas-Martin
Journal:  Cancer Lett       Date:  2010-12-18       Impact factor: 8.679

9.  Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.

Authors:  Rui Li; Yan Qin; Ying He; Wanyin Tao; Nan Zhang; Cheguo Tsai; Paul Zhou; Jin Zhong
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

10.  Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein.

Authors:  Martina Kopp; Catherine L Murray; Christopher T Jones; Charles M Rice
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.